InvestLog
FATE Fate Therapeutics, Inc. logo

FATE Fate Therapeutics, Inc.

Healthcare
$2.25+7.14%ClosedMarket Cap: $262.3M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

11

Dispositions

9

Buy/Sell Ratio

1.22

Net Shares

+45,464

Shares Acquired

13,630,185

Shares Disposed

13,584,721

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21Valamehr Bahramdirector, officer: President and CEOSell28,946$1.88635,762
Thu May 21TAHL CINDYofficer: See RemarksSell25,590$1.88628,155
Thu May 07TAHL CINDYofficer: See RemarksSell122,220$1.32609,301
Thu May 07TAHL CINDYofficer: See RemarksSell44,444$1.05653,745
Wed May 06RASTETTER WILLIAM HdirectorSell25,000$1.6936,331
Wed May 06EPSTEIN ROBERT SdirectorSell25,000$1.6936,331
Thu Apr 23Redmile Group, LLCdirector, 10 percent owner: Sell266,280$5.84502,769
Wed Apr 22Redmile Group, LLCdirector, 10 percent owner: Sell8,977,624$0.0012,884,277
Wed Apr 22Redmile Group, LLCdirector, 10 percent owner: Sell3,691,324$0.003,893,674
Wed Apr 22Redmile Group, LLCdirector, 10 percent owner: Sell266,280$3.02502,769
Wed Apr 22Redmile Group, LLCdirector, 10 percent owner: Sell162,013$0.002,755,086
Fri Jan 16Valamehr Bahramdirector, officer: President and CEOSell1,300,000$1.051,300,000
Fri Jan 16Valamehr Bahramdirector, officer: President and CEOSell335,000$0.00664,708
Fri Jan 16TAHL CINDYofficer: See RemarksSell400,000$1.05400,000
Fri Jan 16TAHL CINDYofficer: See RemarksSell100,000$0.00487,081